Search for Clinical Trial Results
Glycogen Storage Disease Type II - 32 Studies Found
Status | Study |
Completed |
Study Name: A Study to Evaluate the Effects of Pharmacological Chaperones in Cells From Patients With Pompe Disease Condition:
|
Completed |
Study Name: An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease Condition:
|
Completed |
Study Name: A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type II Condition:
|
Recruiting |
Study Name: NeoGAA Extension Study Condition: Glycogen Storage Disease Type II Pompe Disease Date: 2013-12-04 Interventions: Drug: GZ402666 Pharmaceutical form:lyophilized powder reconstituted for infusion Route of administration |
Completed |
Study Name: Newborn Screening Assay of Pompe's Disease Condition: Pompe Disease Date: 2008-07-09 Interventions: Other: Pompe disease newborn screening DBS will be tested for acid alpha-glucosidase (GAA)activity. Newb |
Recruiting |
Study Name: Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe Disease Condition:
|
Terminated |
Study Name: Study to Evaluate the Safety of AT2220 in Pompe Disease Condition: Pompe Disease Date: 2008-05-30 Interventions:
|
Completed |
Study Name: Safety and Efficacy of Clenbuterol on Motor Function in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy Condition: Pompe Disease Date: 2013-09-11 Interventions:
|
Recruiting |
Study Name: A Long Term Follow up Study in Late-onset Pompe Disease Condition: Pompe Disease Date: 2008-07-09 |
Recruiting |
Study Name: A Pilot Study of Pyridostigmine in Pompe Disease Condition: Pompe Disease Date: 2015-01-23 Interventions: Drug: Pyridostigmine Bromide Pyridostigmine is an acetylcholinesterase inhibitor, which increases the am |